Objective: To examine the association between plasma concentrations of C-reactive protein (CRP) and the intake of vitamins and trace elements from supplements possibly related to inflammation such as vitamin C, vitamin E, carotenoids, selenium and zinc. Design: Cross-sectional study using data from the Monitoring of Trends and Determinants in Cardiovascular Disease/ Cooperative Health Research in the Region of Augsburg (MONICA/KORA) Survey 1994/95. Setting: Region of Augsburg, Southern Germany. Subjects: Population-based sample of 2045 women and 2172 men, aged 25-74 years. Results: Intake of dietary supplements containing vitamins and trace elements was associated with lower CRP levels in women.
Introduction
Cardiovascular disease (CVD) is the main cause of death in Western industrialized countries and accounts for 41% of all deaths in Europe (World Health Report, 2004) . A World Health Organization (WHO) cross-cultural study, which surveyed 12 different populations in Europe, showed absolute levels of vitamin E to have a strong, inverse correlation to coronary heart disease (CHD) mortality (Gey et al., 1991) . Epidemiologic studies demonstrated that the intake of certain antioxidant vitamins from supplements, like vitamin E and vitamin C, were associated with reduced risk for CVD morbidity and mortality (Enstrom et al., 1992; Rimm et al., 1993; Stampfer et al., 1993; Losonczy et al., 1996) . A clear inverse association between antioxidants from supplements and CVD would offer new, cost-effective preventive strategies with great public health impact. The inverse association between antioxidants and CVD has been explained on the basis of the oxidative-modification hypothesis of atherosclerosis, which proposes that atherogenesis is initiated by oxidation of lipids in low-density lipoproteins (LDL), termed as lipid peroxidation (Diaz et al., 1997) . The oxidation of lipids in LDL particles initiates a complex sequence of events in the arterial wall, which leads to an inflammatory process and the development of atherosclerotic plaque. Atherosclerosis is considered to be an inflammatory disease (Ross, 1999) , for which C-reactive protein (CRP), a sensitive marker of inflammation, has become a novel risk factor. The role of inflammation for CVD has been demonstrated in several epidemiological studies through the association of plasma CRP and the later development of myocardial infarction or stroke (Ridker et al., 1997 (Ridker et al., , 2000 (Ridker et al., , 2002 Koenig et al., 1999 Koenig et al., , 2004 Pai et al., 2004) . Antioxidants are proposed to inhibit multiple pro-atherogenic and pro-thrombotic oxidative processes in the arterial vessel wall (Tribble, 1999) . According to this hypothesis, antioxidant nutrients like vitamin E, vitamin C, carotenoids as well as selenium or zinc may play a crucial role in the prevention of atherosclerosis and therefore also in the prevention of its clinical manifestations. As associations between CRP and the intake of vitamins and trace elements from supplements have not yet been welldescribed in population-based samples, we examined these associations using data from the Monitoring of Trends and Determinants in Cardiovascular Disease/Cooperative Health Research in the Region of Augsburg (MONICA)/KORA Survey 1994/95.
Subjects and methods
Design and study population The MONICA Augsburg (Germany) project was part of the multinational WHO MONICA project conducted in 38 populations in 21 countries on four continents; the design of both projects has been described elsewhere in detail Tunstall-Pedoe, 1988) . The survey 1994/95 was one of three independent cross-sectional studies carried out in the city of Augsburg and two adjacent counties with the focus on prevalence and distribution of cardiovascular risk factors among men and women. The project is currently continued within the frame of KORA (Cooperative Research in the area of Augsburg). The MONICA/KORA Augsburg study was approved by the local authorities and all participants gave written informed consent. The survey sample comprised of 4856 participants aged 25-74 years (2405 men, 2451 women; response rate: 74.9%). All subjects with missing data on the intake of supplements, CRP-values or any of the considered risk factors, pregnant women and subjects with CRP levels 410 mg/l were excluded (n ¼ 639; 233 men, 406 women). CRP levels 410 mg/l are usually caused by noncardiovascular etiologies (Pearson et al., 2003) . Thus the final analysis was based on data from 2172 men and 2045 women.
Socio-demographic and clinical variables
Information concerning socio-demographic variables, smoking habits, alcohol consumption, physical activity level, prevalence of disease, medication use and intake of vitamins and trace elements from supplements as well as the usual diet was recorded in standardized personal interviews conducted by a trained medical staff. In addition, participants underwent a standardized medical examination including collection of non-fasting blood samples. Exact measurement procedures and laboratory methods have been described elsewhere in detail (Hense et al., 1998; Meisinger et al., 2002; Froehlich et al., 2003) . In the present analysis, actual hypertension was defined as blood pressure X140/ 90 mm Hg or use of anti-hypertensive medication given that these subjects were aware of being hypertensive. CVD was defined as a history of myocardial infarction, stroke or angina pectoris. Subjects were classified as physically active, if they regularly participated in sports during summer and winter for at least 1 h per week. The usual diet was recorded with a food frequency questionnaire, which was described elsewhere in detail (Sell et al., 2003) . To control for potential confounding by dietary habits two variables were defined to characterise subjects with a diet rich in vitamins and rich in fibre, as these dietary factors have been shown to be associated with CRP plasma concentrations (Ajani et al., 2004; Lopez-Garcia et al., 2004) . A 'high vitamin diet' was defined as an almost daily intake of salad, fruits and vegetables and a 'high fibre diet' was defined as an almost daily intake of whole-wheat, dark or crisp bread and oats, muesli or cornflakes.
Supplement use
To assess supplement use all subjects were questioned about their intake of supplemental vitamins, minerals and trace elements within the last 7 days before the interview. Besides information on quantities normally consumed per time interval (i.e. daily, weekly) subjects could state if they took the supplements regularly or as needed. General supplement use was defined as intake of dietary supplements containing at least one vitamin, mineral or trace element. If supplement use was restricted to the intake of only vitamins, selenium or zinc, it will be specifically mentioned. To take into account that many subjects took multivitamin preparations or combined several supplements a 'multivitamin group' was defined. This group contained all subjects taking three or more different vitamins from supplements per day. Quantities of supplement ingredients were calculated based on a supplement composition database, compiled by the GSF National Research Center for Environment and Health. The exact structures of the database and calculation methods have been described elsewhere in detail (Schellhorn et al., 1998) . CRP concentrations were measured by an immunoradiometric assay (range 0.05-10 mg/l) calibrated with the WHO reference standard 85/506 (Hutchinson et al., 2000) .
Statistical analysis
For statistical analyses CRP values were log-transformed and geometric means were calculated, because CRP concentrations were highly skewed. Differences in CRP levels by covariables and supplement intake were compared using analysis of variance (ANOVA). Logistic regression was used to calculate crude and adjusted odds ratios (OR) for the risk of elevated CRP levels. The cut point for 'high CRP' was set at 3 mg/l in accordance with the scientific statement of the American Heart Association and the Centres for Disease Control and Prevention (Pearson et al., 2003) . Variables investigated as potential confounders included age, body mass index (BMI), smoking status, alcohol intake, physical activity, ratio of total cholesterol and high-density lipoprotein-cholesterol(TC/HDL-C), actual hypertension, CVD, diabetes, use of lipid lowering drugs, hormone replacement therapy (HRT), use of oral contraceptives (OC), high vitamin diet and high fibre diet as well as bronchitis, kidney disease, liver disorder, cancer and thyroiditis. The final multivariable adjusted models contained the following covariables: Age, BMI, smoking status, alcohol intake, TC/HDL-C, physical activity, actual hypertension, bronchitis, high vitamin diet and high fibre diet and for women only HRT and OC use. A P-value o0.05 was considered as statistically significant. All analyses were performed with SAS statistical software (version 8.2; SAS Institute Inc., Cary, NC, USA).
Results
Baseline characteristics and prevalence of supplement use of all study participants are given in Table 1 . Supplements containing vitamins, minerals or trace elements were taken by 17.1% (n ¼ 372) of all men and 27.4% (n ¼ 560) of all women. Supplements containing vitamins, selenium or zinc were taken by 10.4% (n ¼ 226) of all men and 15.1% (n ¼ 308) of all women. Multivitamins, which were defined as taking three or more different vitamins from supplements per day, were taken by 6.0% (n ¼ 130) of all men and 8.3% (n ¼ 170) of all women. Table 2 describes the number and percentage of subjects and the median intake of specific vitamins for subjects in the multivitamin group.
The geometric mean CRP concentration in the study population was 1.24 mg/l (95% CI: 1.19, 1.29) for men and 1.29 mg/l (95% CI: 1.23, 1.35) for women ( Table 3) . Most of the examined socio-demographic, clinical and lifestyle characteristics were significantly associated with levels of CRP in men and women. Table 4 shows geometric means of CRP levels by supplement intake. Adjusted geometric means of CRP for female nonusers vs users were 1.31 vs 1.22 mg/l (P ¼ 0.101) for general supplement use, 1.29 vs 1.08 mg/l (P ¼ 0.028) for multivitamin supplements and 1.31 vs 1.09 mg/l (P ¼ 0.007) for vitamin E. Looking at different daily doses of vitamin E the adjusted geometric means of CRP were 1.31 mg/l for nonusers vs 1.17 mg/l for subjects with an intake of 40-12 mg vs 0.99 mg/l for subjects with an intake of 412-67 mg vs 1.05 mg/l for subject with an intake of more than 67 mg (P ¼ 0.036). Twelve milligrams is the recommended daily allowance for vitamin E (DGE, 2000) .
For men, the ANOVA showed no significant differences between nonusers and users of various vitamins or trace elements before or after adjustment for potential confounders. However, levels of CRP tended to be higher among users of carotenoids, selenium, high doses of vitamin C (4500 mg) or vitamin E (467 mg). The mean vitamin E intake of men taking more than 67 mg per day was 253.4 mg. 75.6% of these men were smokers or past smokers. In women, in contrast, the mean vitamin E intake of this group was 228.2 mg, whereas only 36.2% of these were smokers or past smokers. OR for the risk of elevated CRP levels (43 mg/l) according to vitamin and trace element intake are given in Table 5 . For women, the adjusted OR for the intake of multivitamins from supplements compared with those not taking supplements was 0.57 (95% CI: 0.35, 0.91). The respective OR for use of vitamin E from supplements was also 0.57 (95% CI: 0.37, 0.89). Only 17 women took selenium and all had CRP levels o 3 mg/l. For men, the adjusted OR for the intake of vitamin E in doses greater than 67 mg/day was 1.34 (95% CI: 0.63, 2.85) and for the intake of carotenoids from supplements it was 1.98 (95% CI: 0.71, 5.54) compared with those with no intake of vitamin E or carotenoids, respectively. The ORs obtained were very similar when results were not adjusted for dietary variables.
As there were many subjects taking multivitamin supplements, we segmented the study population into four different groups. Group 1 nonusers, group 2 users of supplements (vitamins, selenium or zinc), not taking the analysed vitamin or trace element, group 3 users of supplements taking the analysed vitamin or trace element in combination and group 4 users taking only the analysed vitamin or trace element. OR for the risk of elevated CRP levels (43 mg/l) are given in Table 6 . For carotenoids, selenium and zinc, analyses were restricted to groups 1, 2 and 3 owing to small number. For selenium, ORs could not be calculated for group 3, as there were only three male and no female subjects having elevated CRP levels. For women and the intake of vitamin E the OR for group 3 (users taking vitamin E in combination with other vitamins, selenium or zinc) compared with group 1 (nonusers) was 0.55 (95% CI: 0.36, 0.85) and after adjustment for potential confounding factors 0.62 (95% CI: 0.39, 0.99). For vitamin C, carotenoids, selenium and zinc the OR for group 2 (users taking supplements, but not the analysed one) compared with group 1 (nonusers) remained significant after adjustment for potential confounding factors.
For men and vitamin C, the OR of group 2 (users taking supplements, but not vitamin C) compared with group 1 (nonusers) was 1.99 (95% CI: 1.06, 3.74) and after adjustment for potential confounding factors 1.94 (95% CI: 0.97, 3.90). The adjusted OR of group 3 (users taking supplements together with vitamin C) compared with group 1 (nonusers) was 0.83 (95% CI: 0.50, 1.37). For men and carotenoids, the adjusted OR of group 3 compared with group 1 was 1.99 (95% CI: 0.71, 5.56). Geometric means of CRP concentrations by vitamin or trace element intake stratified for smoking status showed lower geometric means of CRP for male never smokers compared with past smokers and smokers, but no significant differences between nonusers and users of supplements (data not shown).
Discussion
In the present study based on data from the MONICA Augsburg Survey 1994/1995, we found that the intake of certain vitamins and trace elements from supplements was significantly associated with lower CRP concentrations in women. Particularly the intake of vitamin E, selenium and the use of multivitamin supplements seemed to be beneficial. The daily intake of vitamin E and vitamin C in high doses as well as the intake of carotenoids from supplements was associated with elevated CRP levels in men; however, the observed differences were not statistically significant possibly owing to relatively small numbers. As many subjects took multivitamin preparations or combined several supplements, it has to be taken into account for all reported effects of single nutrients, except for those of the group analysis given in Table 6 , that other vitamins and trace elements have potentially supported the observed effect. Multivitamin preparations generally contain lower doses according to the recommendations of the national societies of nutrition. Beneficial effects of some vitamins and trace elements may therefore be caused either by lower doses or by synergistic effects or by both factors.
Male and female study participants were analysed separately in the present study owing to their considerable differences in clinical and lifestyle characteristics, their differences in baseline CRP geometric mean values and reported cardiovascular gender differences (Dubey et al., 2002; Liu et al., 2003; Mercuro et al., 2003; Mendelsohn and Karas, 2005) . Interactions between different lifestyle characteristics, gender factors and vitamin or trace element intake may be responsible for different associations found in women and men. 
Biochemical mechanisms
The study results are concurrent with the following underlying biochemical mechanisms: van Dam et al. (2003) demonstrated that a-tocopherol protected cultured endothelial cells against H 2 O 2 -induced lipid peroxidation and attenuated H 2 O 2 -induced increases in adhesion molecule expression. Therefore, vitamin E supplementation may be especially effective in specific groups of patients exposed to increased oxidative stress, but could be of benefit in healthy individuals as well. Vitamin E is the most prevalent Blood pressure X140/90 mm Hg or use of anti-hypertensive medication given that subjects were aware of being hypertensive.
Intake of vitamins and trace elements from supplements and C-reactive protein AC Scheurig et al antioxidant in LDL-C, needing a lipophilic environment and vitamin C as redox partner for regeneration. Pryor (2000) reported that it is possible or even probable that each condition for which vitamin E provides benefit will have a unique dose-effect curve and different antioxidants appear to act synergistically, thus supplementation with vitamin E might be more effective if combined with other micronutrients. The timing of antioxidant vitamin administration has also been reported to affect CRP levels, which may be one of the reasons for the conflicting results observed in several intervention studies (Carroll and Schade, 2003) . Vitamin C administered as a dietary supplement to healthy humans may exhibit pro-oxidant as well as antioxidant effects depending on the daily dosage; supplementation of 500 mg/day were reported to cause DNA damages owing to oxygen radicals (Podmore et al., 1998) . Selenium is an antioxidant as it is a cofactor of peroxidases and thus detoxifies lipid peroxides (Paolisso et al., 1999) . Intake of vitamins and trace elements from supplements and C-reactive protein AC Scheurig et al
Comparison with the literature To our knowledge, to date, there have been no reports from population-based epidemiological studies investigating the association between CRP and the intake of vitamins or trace elements from supplements. However, Wannamethee et al. (2006) report a significant inverse association of dietary and plasma vitamin C and fruit and vegetable intakes with biomarkers of inflammation in a cross-sectional study of 3258 men aged 60-79 years, who had no history of myocardial infarction, stroke or diabetes. Plasma vitamin C, fruit intake and dietary vitamin C intake (excluding vitamin C from supplements) were significantly and inversely associated with mean concentrations of CRP. Furthermore, the effect of vitamins or trace elements on levels of CRP has been examined in several randomised, doubleblind, placebo-controlled trials. In accordance with our findings, Church et al. (2003) reported a reduction of CRP levels through use of multivitamin supplements in a sample of 87 men and women. CRP levels were significantly lower in the multivitamin group after 6 months, but only plasma levels of vitamin B 6 and vitamin C were inversely associated with CRP levels Contrary to our results, where no significant effect of high dose vitamin C on levels of CRP was observed, Block et al. (2004) demonstrated a 17% (À0.5 mg/l) reduction of plasma CRP (24% after adjustment for baseline plasma CRP and BMI) after 2 months supplementation with high dose vitamin C in healthy adults, actively or passively exposed to cigarette smoke. Our observations of a CRP lowering effect of vitamin E from supplements in women is supported by several intervention studies: A 49% (À2.7 mg/l) significant decrease in CRP levels was shown in patients with type 2 diabetes after 4 weeks of vitamin E (800 IU), but not for vitamin C (Upritchard et al., 2000) . Furthermore, CRP was significantly lower after 6 months intake of vitamin E (400 IU) in smokers with acute coronary syndrome (Murphy et al., 2004) . However, other studies reported a lack of effect of vitamin E or vitamins E þ C on systemic inflammatory markers (Kaul et al., 2001; Bruunsgaard et al., 2003; Vega-Ló pez et al., 2004) . But these studies typically investigated small groups or patients with specific disease characteristics. Besides the antioxidants there were further vitamins in the multivitamin group, for example, B vitamins, which may have beneficial effects on CRP levels. Friso et al., (2001) reported from the Framingham cohort that low circulating vitamin B 6 (PLP) was associated with elevation of CRP independently of plasma homocysteine levels. Furthermore, they showed in a case-control study with 742 participants, that low plasma PLP was inversely related to major markers of inflammation (CRP) and independently associated with increased risk of coronary artery disease (Friso et al., 2004) . As CRP is a measure of inflammation that predicts long-term cardiovascular risk in individuals with no previous evidence of CVD (Koenig et al., 2004; Ridker, 2004) , the present study is also in accordance with the Nurses' health study, where participants taking vitamin E supplements had a relative risk (RR) of a major coronary event of 0.59 (95% CI: 0.38, 0.91) after adjustment for confounding . Intake of folate and vitamin B 6 was associated with a RR for CHD after multivariable adjustment of 0.55 (95% CI: 0.41, 0.74) and the regular use of multiple vitamins, as major source of folate and vitamin B 6 , showed a RR of 0.76 (95% CI: 0.65, 0.90) (Rimm et al., 1998) . In the antioxidant supplementation in atherosclerosis prevention study in 440 men and postmenopausal women (follow up 6 years) supplementation of vitamin E (136 IU) and slow-release vitamin C (250 mg) retarded atherosclerotic progression in hypercholesterolemic persons . In the Women's health study 39 876 healthy women were randomly assigned to receive vitamin E (600 IU) and followed up for an average of 10.1 years. The data indicated that this high dose-vitamin E provided no overall benefit for major cardiovascular events, but cardiovascular mortality in healthy women was significantly reduced with a RR of 0.76 (95% CI: 0.59, 0.98) (Lee et al., 2005) .
Strengths and limitations of the study
The MONICA/KORA Augsburg study has several strengths that need to be mentioned. The study is characterized by its large number of subjects drawn from the general population, for whom a high number of relevant lifestyle and clinical characteristics were available. However, several limitations also need to be considered. First of all we had to rely on selfreported intake of supplements. We included all subjects who took supplements at the time of the interview. Thus, we could not take into account if subjects were already on supplements for years or if they had just started taking them shortly before the interview. Also some subjects indicated that they took the supplements only 'as needed'. As this characterization is very subjective, we performed all major analyses after exclusion of these participants but results were not considerably altered. Furthermore, misclassification of exposure would bias the results towards the null and lead to an underestimation of the real effect. Second, it has been described that people with better health and healthier lifestyle are more likely to take vitamin supplements. As we adjusted in our analysis for a large number of potential confounders, the amount of any residual confounding is, however, probably small. As many subjects took supplements as multivitamin preparations or in combination, it is difficult to determine the effect of any single nutrient or any dose-response relationships for single nutrients. Subgroup analyses in subjects taking single nutrients did provide hints on the effect of specific nutrients such as vitamin E. However, the number of subjects was rather small in some of these subgroups. Therefore, further trials are needed to confirm the effects of single nutrients and to establish dose-response relationships.
Conclusions
In conclusion, we have shown that the combined intake of certain vitamins and trace elements from supplements, for example vitamin E and multivitamins, was significantly associated with lower CRP concentrations in women. Further studies are needed to explore if the observed relationship is causal and if there exists an optimal daily dose for each nutrient with regard to its CRP lowering effect.
